Analyzing the transcriptional response to vortioxetine treatment revealed a reduction of inferred G2M phase cells (Extended Data Fig. 9c) and confirmed glioblastoma-specific induction of AP-1 TFs and effector genes in patient cells (Fig. 6b). The gene discussed is JUN; the disease is glioblastoma.